2017

Micro-fabricated scaffolds lead to efficient remission of diabetes in mice.
Buitinga M, Assen F, Hanegraaf M, Wieringa P, Hilderink J, Moroni L, Truckenmüller R, van Blitterswijk C, Römer GW, Carlotti F, de Koning E, Karperien M, van Apeldoorn A.
Biomaterials. 2017 Mar 27;135:10-22.

Pancreatic α-cell mass in obesity.
Ellenbroek JH, Töns HAM, Hanegraaf MAJ, Rabelink TJ, Engelse MA, Carlotti F, de Koning EJP.
Diabetes Obes Metab. 2017 May 4. doi: 10.1111/dom.12997. [Epub ahead of print]

Stimulation of vascularization of a subcutaneous scaffold applicable for pancreatic islet-transplantation enhances immediate post-transplant islet graft function but not long-term normoglycemia.
Smink AM, Shiri L, Swart DH, Hertsig DT, de Haan BJ, Kamps JAAM, Schwab L, van Apeldoorn AA, de Koning E, Faas MM, Lakey JRT, de Vos P.
J Biomed Mater Res A. 2017 May 3. doi: 10.1002/jbm.a.36101. [Epub ahead of print]

Increased vimentin in human α and β-cells in type 2 diabetes.

Roefs M, Carlotti F, Jones K, Wills H, Hamilton A, Verschoor M, Williams Durkin J, Garcia-Perez L, Brereton M, McCulloch L, Engelse M, Johnson P, Hansen B, Docherty K, de Koning E, Clark A.
J Endocrinol. 2017 Jun;233(3):217-227.

The Efficacy of a Prevascularized, Retrievable Poly(D,L,-lactide-co-E-caprolactone) Subcutaneous Scaffold as Transplantation Site for Pancreatic Islets
Smink AM, Li S, Hertsig DT, de Haan BJ, Schwab L, van Apeldoorn AA, de Koning E, Faas MM, Lakey JR, de Vos P.
Transplantation. 2017 Apr;101(4):e112-e119

Historical Perspectives and Current Challenges in Cell Microencapsulation.
de Vos P
Methods Mol Biol. 2017;1479:3-21